South Korean Stem Cell Firm Enters Into an Agreement with Tiantan Puhua Hospital in China
News Feb 08, 2008
RNL Bio, Co., LTD., on Feb 4, 2008, has entered into an agreement with Beijing Tiantan Puhua Hospital (Puhua) in Beijing, China to establish a joint venture (the firm) and a new hospital to provide patients with stem cell therapeutics.
Dr. Sherwood Yang, Vice president of Puhua agreed with Dr. Jeong Chan Ra, president of CEO of RNL, to open a new stem cell clinic within Puhua hospital through the firm. The new hospital was tentatively named as "RNL-Puhua Stem Cell Medical Center, and will provide stem cell treatments of various degenerative disease including hair loss, aged face and osteoarthritis.
The firm will also supply Puhua hospital with stem cell therapeutics for neurological condition such as spinal cord injury which Puhua is specialized for.
"We are very pleased to have a new hospital for stem cell therapy in China. It will not only advance the commercialization of out stem cell technology but contribute effective stem cell treatment to patients with obsolete complications", said Dr. Ra.
2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
May 30 - May 31, 2019